ArticleTherapeutic advances in neurological disorders2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Celia Oreja-Guevara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.